Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Bamboos Health Care Holdings Ltd ( (HK:2293) ) has shared an update.
Bamboos Health Care Holdings Limited has scheduled a board meeting for 25 February 2026 to review and approve the group’s interim results for the six months ended 31 December 2025. At the same meeting, the board will also consider whether to declare an interim dividend, a decision that could signal management’s confidence in the company’s financial performance and influence returns for shareholders.
The most recent analyst rating on (HK:2293) stock is a Buy with a HK$0.50 price target. To see the full list of analyst forecasts on Bamboos Health Care Holdings Ltd stock, see the HK:2293 Stock Forecast page.
More about Bamboos Health Care Holdings Ltd
Bamboos Health Care Holdings Limited is a Hong Kong-listed company in the healthcare sector, operating through subsidiaries to provide health-related services in its local market. The group is governed by a board comprising executive and independent non-executive directors, reflecting typical corporate governance structures for listed healthcare firms in the region.
Average Trading Volume: 89,844
Technical Sentiment Signal: Sell
Current Market Cap: HK$197.2M
Learn more about 2293 stock on TipRanks’ Stock Analysis page.